Sensatrace
by Ludlow Corp., Technical Papers Division
510(k) K904185
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK904185 | Date31 Oct 1990 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DRX
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.2360
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 26 Sep 2026
Sensatrace is a cardiovascular device classified under product code DRX. It is a substantially equivalent device that received FDA 510(k) clearance on October 31, 1990. The device was submitted by Ludlow Corp., Technical Papers Division and reviewed by the Cardiovascular advisory committee.
Sensatrace is supplied by Ludlow Corp., Technical Papers Division located in Chicopee, MA. The device is regulated under FDA 510(k) clearance with K number K904185. No information regarding sterility, single-use or reusable status, MRI safety, sizes, or storage conditions is provided in the device data.
Questions
AI-generated answers, 26 Sep 2026
What is SENSATRACE used for?
SENSATRACE is a cardiovascular device classified under product code DRX. It is a substantially equivalent device that received FDA 510(k) clearance on October 31, 1990, and was reviewed by the Cardiovascular advisory committee.
Who manufactures SENSATRACE and where is it supplied from?
SENSATRACE is manufactured and supplied by Ludlow Corp., Technical Papers Division, located in Chicopee, MA. The company serves as the applicant for this device with FDA clearance number K904185.
What is the regulatory status of SENSATRACE?
SENSATRACE is regulated under FDA 510(k) clearance with K number K904185. It was classified as substantially equivalent and received traditional clearance on October 31, 1990, after review by the Cardiovascular advisory committee.
Is information available about sterility, single-use status, or storage conditions for SENSATRACE?
No information regarding sterility, single-use or reusable status, MRI safety, sizes, or storage conditions is provided in the device data for SENSATRACE.